Free Trial

The Allstate Co. (NYSE:ALL) Stake Reduced by Edmond DE Rothschild Holding S.A.

Allstate logo with Finance background
Remove Ads

Edmond DE Rothschild Holding S.A. cut its stake in shares of The Allstate Co. (NYSE:ALL - Free Report) by 26.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 70,278 shares of the insurance provider's stock after selling 25,000 shares during the quarter. Edmond DE Rothschild Holding S.A.'s holdings in Allstate were worth $13,549,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Allstate by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 32,635,424 shares of the insurance provider's stock worth $6,291,783,000 after purchasing an additional 389,426 shares in the last quarter. State Street Corp lifted its holdings in shares of Allstate by 1.1% in the third quarter. State Street Corp now owns 11,496,306 shares of the insurance provider's stock valued at $2,190,758,000 after purchasing an additional 126,922 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Allstate by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider's stock valued at $1,178,164,000 after purchasing an additional 74,537 shares during the last quarter. GQG Partners LLC increased its stake in shares of Allstate by 64.1% during the 4th quarter. GQG Partners LLC now owns 4,316,516 shares of the insurance provider's stock worth $832,181,000 after purchasing an additional 1,685,694 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Allstate by 1.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,834,172 shares of the insurance provider's stock worth $353,610,000 after acquiring an additional 19,463 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Allstate Stock Performance

NYSE ALL traded down $0.03 during trading hours on Thursday, reaching $205.40. The company's stock had a trading volume of 1,342,423 shares, compared to its average volume of 1,575,396. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The business has a 50-day simple moving average of $196.94 and a 200 day simple moving average of $194.28. The Allstate Co. has a 52 week low of $156.66 and a 52 week high of $212.91. The stock has a market cap of $54.44 billion, a PE ratio of 12.10, a PEG ratio of 1.01 and a beta of 0.47.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Equities research analysts predict that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.

Allstate Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 10th were issued a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.95%. The ex-dividend date was Monday, March 10th. This is a boost from Allstate's previous quarterly dividend of $0.92. Allstate's dividend payout ratio (DPR) is 23.54%.

Allstate announced that its board has authorized a share repurchase program on Wednesday, February 26th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the insurance provider to purchase up to 3% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. StockNews.com cut Allstate from a "buy" rating to a "hold" rating in a report on Monday. Barclays lowered their target price on Allstate from $187.00 to $183.00 and set an "underweight" rating for the company in a research note on Monday, January 6th. Wells Fargo & Company boosted their price target on Allstate from $186.00 to $187.00 and gave the stock an "equal weight" rating in a research report on Tuesday, January 14th. Evercore ISI upgraded shares of Allstate from an "in-line" rating to an "outperform" rating in a research note on Wednesday, January 8th. Finally, Keefe, Bruyette & Woods upped their target price on shares of Allstate from $235.00 to $240.00 and gave the company an "outperform" rating in a research note on Tuesday, February 11th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $219.80.

Check Out Our Latest Analysis on Allstate

Insider Activity at Allstate

In other news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares of the company's stock, valued at approximately $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.80% of the stock is currently owned by insiders.

About Allstate

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Further Reading

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Donald Trump Owns These 7 Stocks, Should You?

Donald Trump Owns These 7 Stocks, Should You?

He’s one of the most talked-about billionaires in the world—but when it comes to investing, Donald Trump’s stock picks are shockingly… low-key.

Recent Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads